Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 14.28 is 72% above its 1-year average of 8.30, near the high end of its 1-year range (0.00–14.28).
As of the fiscal period ended Tuesday, June 30, 2026. 28.96% above its 12-month average of 11.07.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 14.28.
CURRENT RATIO
14.28
CURRENT RATIO AVG TTM
11.07
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+28.96%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+279.79%
vs the sector median at left
First Tracks Biotherapeutics Inc
Market Cap
$1.10B
Current Ratio
14.28
TTM Avg
11.07
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.09B
Current Ratio
11.59
TTM Avg
21.25
3Y Avg
14.51
5Y Avg
14.51
Market Cap
$1.11B
Current Ratio
3.18
TTM Avg
2.74
3Y Avg
3.61
5Y Avg
4.46
Market Cap
$1.13B
Current Ratio
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| First Tracks Biotherapeutics Inc (TRAX) | $1.10B | 14.28 | 11.07 | N/A | N/A |
| OPKO Health, Inc. (OPK)vs › | $1.09B | 3.35 | 3.70 | 2.70 | 2.45 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 11.59 | 21.25 | 14.51 | 14.51 |
| STAAR Surgical Company (STAA)vs › | $1.10B | 4.66 | 4.55 | 5.13 | 5.40 |
| IRadimed Corporation (IRMD)vs › | $1.08B | 9.46 | 8.41 | 7.63 | 9.11 |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | 3.18 | 2.74 | 3.61 | 4.46 |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 5.23 | 6.37 | 10.25 | 15.62 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 33.10 | 10.19 | 10.19 | 10.19 |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 2.24 | 2.14 | 3.36 | 3.91 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 1.38 | 3.96 | 6.78 | 9.79 |
Current Ratio
14.28
Quick Ratio
14.28
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 14.28 |
| 2026-03-31 | 8.74 |
| 2025-12-31 | 10.20 |
| 2025-03-31 | 0.00 |
